Bempedoic Acid Cuts CV Events in Statin-Intolerant Patients
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL-lowering therapies, experts say.
Stay updated with breaking news from Presented March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL-lowering therapies, experts say.
As important as the care of Ukrainian citizens with cancer is to clinicians in that country, this priority has been overshadowed by more immediate concerns.“At this time, the Russian occupants have destroyed more than 117 hospitals, 43 ambulances were fired up, and six doctors were killed,” Andriy Hrynkiv, MD,
Those assigned to CT angiography vs invasive angiography fared at least as well for clinical outcomes but had far fewer procedure-related complications in the pan-European DISCHARGE trial.